These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6214261

  • 1. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF, Lock CJ, Howard-Lock HE, Buchanan WW.
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [Abstract] [Full Text] [Related]

  • 2. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR, Ström H, Bjelle A, Möller E.
    Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
    [Abstract] [Full Text] [Related]

  • 3. Adverse reactions to D-penicillamine after gold toxicity.
    Dodd MJ, Griffiths ID, Thompson M.
    Br Med J; 1980 Jun 21; 280(6230):1498-500. PubMed ID: 6770953
    [Abstract] [Full Text] [Related]

  • 4. The toxicity of D-penicillamine in systemic sclerosis.
    Steen VD, Blair S, Medsger TA.
    Ann Intern Med; 1986 May 21; 104(5):699-705. PubMed ID: 2938530
    [Abstract] [Full Text] [Related]

  • 5. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
    Palosuo T, Kajander A, von Essen R, Milgrom F.
    Clin Immunol Immunopathol; 1978 Jul 21; 10(3):355-64. PubMed ID: 97039
    [No Abstract] [Full Text] [Related]

  • 6. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ.
    N Engl J Med; 1980 Aug 07; 303(6):300-2. PubMed ID: 6770269
    [Abstract] [Full Text] [Related]

  • 7. Gold vs D-penicillamine double blind study and followup.
    Thomas MH, Rothermich NO, Philips VK, Bergen W, Hedrick SW.
    J Rheumatol; 1984 Dec 07; 11(6):764-7. PubMed ID: 6240537
    [Abstract] [Full Text] [Related]

  • 8. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z, Borso G, Marinković M, Winter Fudurić I, Pucar I, Cikes N.
    Acta Med Iugosl; 1987 Dec 07; 41(5):363-72. PubMed ID: 3128058
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly.
    Kean WF, Anastassiades TP, Dwosh IL, Ford PM, Kelly WG, Dok CM.
    J Am Geriatr Soc; 1982 Feb 07; 30(2):94-100. PubMed ID: 6460054
    [Abstract] [Full Text] [Related]

  • 10. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E.
    Med Clin (Barc); 1985 Jun 08; 85(2):73-9. PubMed ID: 3160899
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K.
    J Rheumatol Suppl; 1982 Jun 08; 8():197-200. PubMed ID: 6813485
    [Abstract] [Full Text] [Related]

  • 12. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
    Farr M, Kitas G, Bacon PA.
    Clin Rheumatol; 1988 Jun 08; 7(2):242-8. PubMed ID: 2901303
    [Abstract] [Full Text] [Related]

  • 13. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
    Kean WF, Dwosh IL, Anastassiades TP, Ford PM, Kelly HG.
    Arthritis Rheum; 1980 Feb 08; 23(2):158-64. PubMed ID: 7362666
    [Abstract] [Full Text] [Related]

  • 14. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E, Kåss E.
    J Rheumatol Suppl; 1981 Feb 08; 7():107-11. PubMed ID: 6785435
    [Abstract] [Full Text] [Related]

  • 15. Influence of previous gold toxicity on subsequent development of penicillamine toxicity.
    Smith PJ, Swinburn WR, Swinson DR, Stewart IM.
    Br Med J (Clin Res Ed); 1981 Feb 08; 285(6342):595-6. PubMed ID: 6218857
    [Abstract] [Full Text] [Related]

  • 16. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C, Boki K, Varla-Leftherioti M, Kappos-Rigatou I, Fostiropoulos G, Economidou J.
    Dis Markers; 1986 Jun 08; 4(1-2):35-41. PubMed ID: 3133153
    [Abstract] [Full Text] [Related]

  • 17. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
    Huskisson EC, Gibson TJ, Balme HW, Berry H, Burry HC, Grahame R, Hart FD, Henderson DR, Wojtulewski JA.
    Ann Rheum Dis; 1974 Nov 08; 33(6):532-5. PubMed ID: 4216306
    [No Abstract] [Full Text] [Related]

  • 18. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb NJ.
    J Rheumatol; 1984 Oct 08; 11(5):610-4. PubMed ID: 6439866
    [Abstract] [Full Text] [Related]

  • 19. Sequential gold and penicillamine therapy in rheumatoid arthritis.
    Halla JT, Cassady J, Hardin JG.
    Am J Med; 1982 Mar 08; 72(3):423-6. PubMed ID: 6174045
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of rheumatoid arthritis with gold salts].
    Aranguena L, Hinojosa W, Chincaro C, Portugal J, Barrenechea O.
    Rev Clin Esp; 1982 Mar 08; 173(5-6):305-8. PubMed ID: 6238373
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.